Robotic Exoskeletons for Post-Surgery Recovery

(REACT-CVTS Trial)

This trial explores the use of a robotic exoskeleton for walking after cardiovascular or thoracic surgery to aid recovery compared to standard care. Researchers aim to determine if patients can begin walking sooner and assess the safety and practicality of this technology. The trial seeks participants who have undergone major heart or lung surgery and require additional support to get up and move. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve recovery options for future patients.

The trial information does not specify if you need to stop taking your current medications. However, certain medications like moderate vasopressors or inotropes are part of the exclusion criteria, so it's best to discuss your specific medications with the trial team.

Research has shown that overground robotic exoskeletons, like those studied for recovery after surgery, have generally been well-received in earlier trials. These studies found that they help people walk faster and improve their walking style. So far, no major safety issues have been reported. Unexpected problems have been rare, and most participants completed their therapy sessions without trouble. This technology has been tested in various environments, showing promising results in helping people regain movement after surgery.¹²³⁴⁵

Researchers are excited about the use of overground robotic exoskeletons for post-surgery recovery because they offer a new approach to early ambulation. Unlike the standard care that mainly relies on traditional physical therapy, these exoskeletons provide mechanical support that can help patients walk sooner and potentially improve recovery times. The technology allows for precise control of movement, which can aid in regaining mobility more efficiently. This innovative method could revolutionize how we assist patients in their recovery journey, making the rehabilitation process faster and possibly more effective.

This trial will compare overground robotic exoskeleton early ambulation (ORE-EA) with usual care early ambulation (UC-EA) for post-surgery recovery. Studies have shown that overground robotic exoskeletons can help people walk faster and with fewer issues. Research indicates these devices effectively improve walking in stroke patients. One study found that this technology enhanced walking speed and movement across various groups. In terms of safety, these exoskeletons have been well-tolerated, with no serious side effects reported. These findings suggest that robotic exoskeletons may help patients regain their ability to walk after surgery.¹²⁵⁶⁷